Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,723 | 17,456 | 21,952 | 20,723 | 21,179 |
| Receivables | 7,862 | 7,525 | 10,694 | 11,194 | 11,511 |
| Inventories | 8,139 | 9,058 | 9,534 | 8,902 | 8,925 |
| Other current assets | 1,370 | 0 | 2 | 3,555 | 0 |
| TOTAL | $29,094 | $35,400 | $44,095 | $44,374 | $43,751 |
| Non-Current Assets | |||||
| PPE Net | 1,338 | 997 | 965 | 1,127 | 1,569 |
| Intangibles | 105,626 | 122,122 | 162,344 | 195,018 | 229,181 |
| Other Non-Current Assets | 1,471 | 1,385 | 1,656 | 1,133 | 1,404 |
| TOTAL | $108,435 | $124,504 | $164,965 | $197,278 | $232,154 |
| Total Assets | $137,529 | $159,904 | $209,060 | $241,652 | $275,905 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,325 | 4,828 | 4,692 | 13,056 | 12,000 |
| Accounts payable and accrued liabilities | 10,438 | 8,709 | 14,107 | 11,591 | 9,316 |
| Other current liabilities | N/A | 33 | 1,720 | 1,887 | 901 |
| TOTAL | $26,121 | $22,545 | $26,688 | $31,190 | $27,672 |
| Non-Current Liabilities | |||||
| Long Term Debt | 44,453 | 60,740 | 82,045 | 83,279 | 84,134 |
| Other Non-Current Liabilities | 1,673 | 778 | 1,768 | 817 | 1,884 |
| TOTAL | $49,738 | $66,018 | $84,675 | $85,144 | $87,497 |
| Total Liabilities | $75,859 | $88,563 | $111,363 | $116,334 | $115,169 |
| Shareholders' Equity | |||||
| Common Shares | 256,338 | 260,595 | 262,127 | 265,206 | 265,917 |
| Retained earnings | -204,152 | -194,180 | -175,457 | -148,449 | -119,857 |
| Other shareholders' equity | -6,680 | -10,210 | -2,838 | -5,260 | 2,959 |
| TOTAL | $61,670 | $71,341 | $97,697 | $125,318 | $160,736 |
| Total Liabilities And Equity | $137,529 | $159,904 | $209,060 | $241,652 | $275,905 |